These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8204775)

  • 1. Assessment of new therapies for infection due to the Mycobacterium avium complex: appropriate use of in vitro and in vivo testing.
    Grosset JH
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S233-6. PubMed ID: 8204775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
    Brown-Elliott BA; Philley JV; Griffith DE; Thakkar F; Wallace RJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
    J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar serovar and drug susceptibility profiles among AIDS-related Mycobacterium avium isolates from diverse geographic locations.
    Jacobs NJ; Fordham Von Reyn C; Gine N; Dawson D
    Am J Med Sci; 1997 Jun; 313(6):352-4. PubMed ID: 9186150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations.
    Andréjak C; Almeida DV; Tyagi S; Converse PJ; Ammerman NC; Grosset JH
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2129-35. PubMed ID: 25624335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the selection of clarithromycin-resistant Mycobacterium avium-intracellulare complex.
    Grosset J; Ji B
    Drugs; 1997; 54 Suppl 2():23-7; discussion 28-9. PubMed ID: 9358197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility testing of Mycobacterium avium complex isolates.
    Heifets L
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1759-67. PubMed ID: 8843278
    [No Abstract]   [Full Text] [Related]  

  • 9. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.
    Mehta RT
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
    Huang CC; Wu MF; Chen HC; Huang WC
    J Microbiol Immunol Infect; 2018 Oct; 51(5):636-643. PubMed ID: 28705770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
    Fattorini L; Vincent V; Li B; Xiao Y; Varnerot A; Tortoli E; Piersimoni C; Mandler F; Mascellino MT; Iona E; Orefici G
    J Chemother; 1996 Feb; 8(1):37-42. PubMed ID: 8835106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Aralar P; Young LS
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2210-4. PubMed ID: 11451676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in the management of Mycobacterium avium complex infection in AIDS patients.
    Peloquin CA
    Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo synergistic effect of isoniazid with streptomycin and clofazimine against Mycobacterium avium complex (MAC).
    Reddy MV; Srinivasan S; Gangadharam PR
    Tuber Lung Dis; 1994 Jun; 75(3):208-12. PubMed ID: 7919314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beige mouse model for Mycobacterium avium complex (MAC) disease: optimal conditions for the host and parasite.
    Gangadharam PR; Perumal VK; Farhi DC; LaBrecque J
    Tubercle; 1989 Dec; 70(4):257-71. PubMed ID: 2626803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
    Petersen EA; Grayson JB; Hersh EM; Dorr RT; Chiang SM; Oka M; Proffitt RT
    J Antimicrob Chemother; 1996 Nov; 38(5):819-28. PubMed ID: 8961051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium avium disease: progress at last.
    Bates JH
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1737-8. PubMed ID: 8665029
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired resistance in Mycobacterium avium complex strains isolated from AIDS patients and beige mice during treatment with clarithromycin.
    Doucet-Populaire F; Truffot-Pernot C; Grosset J; Jarlier V
    J Antimicrob Chemother; 1995 Jul; 36(1):129-36. PubMed ID: 8537260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
    Deshpande D; Gumbo T
    Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.